NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.
Febbo PG, Ladanyi M, Aldape KD, De Marzo AM, Hammond ME, Hayes DF, Iafrate AJ, Kelley RK, Marcucci G, Ogino S, Pao W, Sgroi DC, Birkeland ML.
Febbo PG, et al. Among authors: kelley rk.
J Natl Compr Canc Netw. 2011 Nov;9 Suppl 5:S1-32; quiz S33. doi: 10.6004/jnccn.2011.0137.
J Natl Compr Canc Netw. 2011.
PMID: 22138009